datetime,symbol,name,exchange,begin_date,marketCap,open,high,low,close,adjClose,volume,unadjustedVolume,change,changePercent,vwap
2015-02-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20872500.0,90.0,97.5,75.0,90.75,90.75,10900.0,10900.0,6.09,1.4338571428571432,89.13714285714286
2015-03-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,12075000.0,90.0,90.0,41.1,52.5,52.5,1200.0,1200.0,-7.95,-1.6082,63.2
2015-04-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,13800000.0,58.8,60.0,58.8,60.0,60.0,200.0,200.0,0.6,0.51,59.7
2015-05-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,28350000.0,75.0,75.0,67.5,67.5,67.5,400.0,400.0,0.0,0.0,71.25
2015-06-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,31500000.0,67.5,75.0,67.5,75.0,75.0,200.0,200.0,7.5,5.5555,70.0
2015-07-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,45045000.0,82.5,405.0,82.5,107.25,107.25,58200.0,58200.0,86.54999999999997,8.101999999999999,211.83333333333334
2015-08-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,27000000.0,112.5,112.5,53.25,56.25,56.25,90300.0,90300.0,-51.989999999999995,-2.739571428571429,69.98380952380954
2015-09-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20232000.0,53.4,77.85,41.7,42.15,42.15,40000.0,40000.0,-18.675,-1.6289000000000002,56.951249999999995
2015-10-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,19080000.0,49.2,55.635,38.25,39.75,39.75,8100.0,8100.0,-10.139999999999999,-1.1049375,46.90593750000001
2015-11-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,23103000.0,39.75,75.0,35.85,45.3,45.3,363800.0,363800.0,7.920000000000001,1.8170500000000005,47.0985
2015-12-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20961000.0,46.5,46.5,36.0,41.1,41.1,28300.0,28300.0,-17.355,-1.8146363636363638,40.970454545454544
2016-01-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,13005000.0,40.11,41.85,20.7,25.5,25.5,55800.0,55800.0,-23.609999999999996,-3.8773888888888886,29.910833333333333
2016-02-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,28080000.0,27.0,63.0,26.85,54.0,54.0,776100.0,776100.0,17.19,4.536549999999998,44.51075
2016-03-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,24024000.0,53.85,76.5,43.95,46.2,46.2,229600.0,229600.0,-34.96500000000001,-2.6227272727272726,53.00454545454545
2016-04-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,27300000.0,45.45,58.95,44.85,52.5,52.5,59700.0,59700.0,-4.56,-0.3111428571428571,49.91666666666668
2016-05-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,31500000.0,51.9,60.0,44.55,56.25,56.25,68800.0,68800.0,-1.859999999999999,-0.04395238095238087,49.63833333333334
2016-06-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,21756000.0,56.25,57.315,36.3,38.85,38.85,62600.0,62600.0,-10.575000000000003,-0.8617727272727271,46.27227272727273
2016-07-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,16968000.0,38.25,39.525,30.15,30.3,30.3,18800.0,18800.0,-10.049999999999999,-1.4653684210526314,36.37842105263158
2016-08-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,16461000.0,35.4,45.0,25.35,26.55,26.55,207300.0,207300.0,-5.264999999999999,-0.6470434782608695,28.721304347826088
2016-09-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,15996000.0,26.25,34.35,19.65,25.8,25.8,216100.0,216100.0,-4.47,-0.734190476190476,25.069047619047616
2016-10-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,13764000.0,25.5,26.85,19.95,22.2,22.2,62900.0,62900.0,-5.954999999999998,-1.127809523809524,24.481666666666666
2016-11-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,16830000.0,22.2,31.5,16.65,25.5,25.5,603400.0,603400.0,-1.8600000000000012,0.09866666666666654,22.91595238095238
2016-12-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,16137000.0,25.35,31.5,23.25,24.45,24.45,272500.0,272500.0,-6.854999999999999,-1.136190476190476,25.624285714285715
2017-01-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,15180000.0,24.75,33.3,21.315,22.995,22.995,463200.0,463200.0,-6.405,-1.1082,24.3065
2017-02-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,27930000.0,22.95,58.5,22.44,39.9,39.9,3219800.0,3219800.0,13.049999999999997,2.3616315789473683,30.07605263157895
2017-03-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,26775000.0,39.75,46.5,32.25,38.25,38.25,654300.0,654300.0,2.0100000000000002,0.32417391304347826,38.021086956521735
2017-04-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20580000.0,37.95,37.95,28.2,29.4,29.4,92600.0,92600.0,-4.200000000000001,-0.5958947368421051,32.79315789473685
2017-05-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,22680000.0,28.65,36.45,26.25,28.35,28.35,300900.0,300900.0,-2.76,-0.32490909090909087,28.36181818181818
2017-06-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,16440000.0,28.5,29.55,18.15,20.55,20.55,435200.0,435200.0,-2.8649999999999998,-0.5134090909090909,21.99954545454546
2017-07-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,16080000.0,20.7,22.05,19.2,20.1,20.1,248900.0,248900.0,-0.7500000000000001,-0.15099999999999997,20.448749999999997
2017-08-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,17077500.0,20.25,20.25,13.5,14.85,14.85,273000.0,273000.0,-6.060000000000002,-1.3221304347826084,15.679565217391307
2017-09-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20182500.0,14.7,19.2,14.43,17.55,17.55,461700.0,461700.0,3.4500000000000006,1.2146000000000003,17.294000000000004
2017-10-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,19032500.0,18.45,19.5,14.775,16.545,16.545,198500.0,198500.0,-3.51,-0.7985000000000002,17.00159090909091
2017-11-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,18630000.0,16.8,19.5,15.15,16.2,16.2,252700.0,252700.0,-2.2199999999999998,-0.47695238095238085,16.5952380952381
2017-12-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,18457500.0,16.5,20.7,15.45,16.05,16.05,723000.0,723000.0,-1.9199999999999993,-0.4011000000000001,18.0405
2018-01-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,17940000.0,16.35,20.1,15.0,15.6,15.6,414500.0,414500.0,-2.37,-0.5761904761904763,17.735714285714284
2018-02-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,9832500.0,15.75,16.2,7.425,8.55,8.55,553800.0,553800.0,-3.0299999999999994,-1.473052631578947,10.086315789473682
2018-03-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,6555000.0,8.4,10.95,4.98,5.7,5.7,332800.0,332800.0,-3.435,-1.8864285714285716,8.090714285714284
2018-04-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,9131000.0,5.7,12.0,4.35,7.935,7.935,4501200.0,4501200.0,-1.9949999999999999,0.05833333333333374,6.832142857142857
2018-05-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,21075000.0,7.545,9.75,6.33,8.43,8.43,1000600.0,1000600.0,-0.7050000000000001,-0.15736363636363648,8.333409090909091
2018-06-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,19875000.0,8.25,9.3,7.545,7.95,7.95,423200.0,423200.0,-0.9299999999999999,-0.3902380952380953,8.308571428571428
2018-07-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20000000.0,7.95,12.9,7.2,7.995,7.995,1123900.0,1123900.0,-1.68,-0.5021904761904763,8.474523809523811
2018-08-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,24186792.0,7.86,8.55,7.65,8.4,8.4,251200.0,251200.0,0.33000000000000007,0.1964782608695652,8.08108695652174
2018-09-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,13389117.0,7.35,7.65,4.5,4.65,4.65,793900.0,793900.0,-2.8049999999999993,-2.3319999999999994,5.641578947368421
2018-10-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,13389117.0,4.89,7.665,4.125,4.65,4.65,2065600.0,2065600.0,-1.4549999999999996,-1.063608695652174,5.663478260869565
2018-11-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,22123407.9,5.025,9.6,4.575,7.59,7.59,3015600.0,3015600.0,0.81,0.9117142857142857,6.702857142857144
2018-12-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20345373.8,7.8,8.25,5.7,6.975,6.975,442600.0,442600.0,-1.0050000000000003,-0.3506842105263157,7.113157894736844
2019-01-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,21219816.8,6.6,8.835,6.45,7.275,7.275,402100.0,402100.0,3.7199999999999998,2.6603333333333334,7.396904761904761
2019-02-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,28998942.0,7.05,7.395,6.015,6.45,6.45,152300.0,152300.0,0.735,0.6225789473684211,6.754473684210526
2019-03-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,20546537.2,6.375,7.2,4.38,4.575,4.575,6441600.0,6441600.0,-1.7699999999999998,-1.2870000000000001,6.038571428571427
2019-04-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,19557426.0,4.545,5.535,4.2,4.35,4.35,3599800.0,3599800.0,-0.8250000000000001,-0.7067142857142857,4.835000000000001
2019-05-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,10979839.2,4.29,5.385,3.15,3.765,3.765,13053900.0,13053900.0,-0.5849999999999997,-0.3905909090909093,3.735909090909091
2019-06-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,10512612.0,5.895,5.94,3.45,3.6,3.6,14004300.0,14004300.0,-3.5850000000000004,-3.8537,3.830749999999999
2019-07-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,9052527.0,3.6,4.2,3.0,3.105,3.105,5999700.0,5999700.0,-1.0649999999999997,-1.3134090909090907,3.53840909090909
2019-08-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,7576794.6,3.15,3.6,2.25,2.54,2.54,4567000.0,4567000.0,-0.8899999999999999,-1.1623636363636363,2.879318181818181
2019-09-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,9515738.1,2.45,4.421,2.329,3.19,3.19,842100.0,842100.0,0.9590000000000001,2.0301,3.2217665
2019-10-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,11782810.5,3.14,4.1,2.75,3.95,3.95,324300.0,324300.0,0.973,1.5132173913043476,3.30701347826087
2019-11-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,29628457.6,4.0,9.5,3.64,7.838,7.838,17786200.0,17786200.0,0.05899999999999994,0.7611500000000001,5.094316
2019-12-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,37866982.8,8.05,12.89,6.26,10.02,10.02,3504100.0,3504100.0,3.563,2.0829523809523813,7.856064285714287
2020-01-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,21692263.6,10.19,10.19,5.6,5.74,5.74,2047700.0,2047700.0,-4.500000000000001,-2.642666666666667,7.291142380952381
2020-02-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,26017255.0,5.74,7.93,5.05,5.75,5.75,1147600.0,1147600.0,0.6739999999999999,0.7211578947368421,6.367439473684212
2020-03-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,23528648.0,5.75,6.6,3.5,5.2,5.2,2983700.0,2983700.0,-1.27,-0.7394090909090907,4.522530909090909
2020-04-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,23573895.4,4.92,6.2,4.53,5.21,5.21,1198900.0,1198900.0,0.19799999999999998,0.2818571428571428,5.464063809523809
2020-05-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,23104193.4,5.22,5.7,4.621,5.1,5.1,699900.0,699900.0,-0.738,-0.67665,5.0764495
2020-06-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,21790425.54,5.1,5.75,4.8,4.81,4.81,573900.0,573900.0,-0.48999999999999994,-0.3950909090909091,5.119650909090908
2020-07-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,18483354.72,4.81,5.3,4.04,4.08,4.08,705900.0,705900.0,-1.1660000000000001,-1.0732727272727274,4.813273636363635
2020-08-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,18392750.04,4.12,6.5,3.35,4.06,4.06,11925736.0,11925736.0,-0.5499999999999998,-0.3977142857142856,4.479618095238094
2020-09-01,EYEG,Eyegate Pharmaceuticals Inc.,NASDAQ,2015-02-13,17250708.0,4.0,4.12,3.51,3.8,3.8,344460.0,344460.0,-0.5900000000000001,-1.3695454545454546,3.8370854545454547
